TITLE:
Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy

CONDITION:
Anemia

INTERVENTION:
epoetin alfa

SUMMARY:

      The purpose of this study is to determine the effectiveness of different doses of epoetin
      alfa for treating anemia in patients who have cancer; or patients who no longer have any
      signs of cancer, but remain anemic as a result of their treatment. These patients should not
      be currently receiving chemotherapy or radiotherapy. A subject's participation in the study
      will last approximately 6 months. Subjects will receive weekly doses of epoetin alfa or
      placebo. Their hemoglobin will be tested every week.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Body weight >/=99 lbs

          -  ECOG 0-2

          -  Anemia results from cancer, chemotherapy, radiotherapy or an association with
             hormonal therapy or immunotherapy

          -  Screening hemoglobin level of </=11.0 g/dL for men or </=10.0 for women
      
